UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study

Journal of clinical oncology, 2008-04, Vol.26 (12), p.2013-2019

2008

Volltextzugriff (PDF)

Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer

Journal of clinical oncology, 2008-04, Vol.26 (12), p.2006-2012

2008

Volltextzugriff (PDF)

Prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis in metastatic colorectal cancer

British journal of cancer, 2018-12, Vol.119 (12), p.1464-1470

2018

Volltextzugriff (PDF)

Robust discrete‐time output feedback stabilization of integrator chains

International journal of robust and nonlinear control, 2023-10, Vol.33 (15), p.9233-9250

2023

Volltextzugriff (PDF)

Implicit and explicit discrete‐time realizations of homogeneous differentiators

International journal of robust and nonlinear control, 2021-06, Vol.31 (9), p.3606-3630

2021

Volltextzugriff (PDF)

Persistent diarrhea in immunocompromised patients: Have you ever thought about an astrovirus infection?

Transplant infectious disease, 2024-06, Vol.26 (3), p.e14276-n/a

2024

Volltextzugriff (PDF)

Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study

Journal of clinical oncology, 2023-07, Vol.41 (21), p.3663-3669

2023

Volltextzugriff (PDF)

Patterns of spatial and temporal variability in streamflow records in south central Chile in the period 1952-2003

Water resources research, 2010-05, Vol.46 (5), p.n/a

2010

Volltextzugriff (PDF)

SOD3 improves the tumor response to chemotherapy by stabilizing endothelial HIF-2α

Nature communications, 2018-02, Vol.9 (1), p.575-18, Article 575

2018

Volltextzugriff (PDF)

Optimal maintenance strategy following FOLFOX plus anti-EGFR induction therapy in patients with RAS wild type metastatic colorectal cancer: An individual patient data pooled analysis of randomised clinical trials

European journal of cancer (1990), 2023-09, Vol.190, p.112945-112945, Article 112945

2023

Volltextzugriff (PDF)

Intramolecular CH Activation through Gold(I)-Catalyzed Reaction of Iodoalkynes

Angewandte Chemie International Edition, 2015-03, Vol.54 (10), p.3052-3055

2015

Volltextzugriff (PDF)

Phase II Trial of Cetuximab in Combination With Fluorouracil, Leucovorin, and Oxaliplatin in the First-Line Treatment of Metastatic Colorectal Cancer

Journal of clinical oncology, 2007-11, Vol.25 (33), p.5225-5232

2007

Volltextzugriff (PDF)

Behavioural and structural interventions in cancer prevention: towards the 2030 SDG horizon

Molecular oncology, 2021-03, Vol.15 (3), p.801-808

2021

Volltextzugriff (PDF)

Phase III Study of Capecitabine Plus Oxaliplatin Compared With Continuous-Infusion Fluorouracil Plus Oxaliplatin As First-Line Therapy in Metastatic Colorectal Cancer: Final Report of the Spanish Cooperative Group for the Treatment of Digestive Tumors Trial

Journal of clinical oncology, 2007-09, Vol.25 (27), p.4224-4230

2007

Volltextzugriff (PDF)

Circulating Tumor Cell Count Is a Prognostic Factor in Metastatic Colorectal Cancer Patients Receiving First‐Line Chemotherapy Plus Bevacizumab: A Spanish Cooperative Group for the Treatment of Digestive Tumors Study

The oncologist (Dayton, Ohio), 2012-07, Vol.17 (7), p.947-955

2012

Volltextzugriff (PDF)

Time–Frequency Approach for Cutting Tool Power Signal Separation in Face Milling Operations

Applied Mechanics, 2024-03, Vol.5 (1), p.180-191

2024

Volltextzugriff (PDF)

Colon cancer molecular subtypes identified by expression profiling and associated to stroma, mucinous type and different clinical behavior

BMC cancer, 2012-06, Vol.12 (1), p.260-260

2012

Volltextzugriff (PDF)

XELOX (Capecitabine Plus Oxaliplatin): Active First-Line Therapy for Patients With Metastatic Colorectal Cancer

Journal of clinical oncology, 2004-06, Vol.22 (11), p.2084-2091

2004

Volltextzugriff (PDF)

Tumor burden monitoring using cell-free tumor DNA could be limited by tumor heterogeneity in advanced breast cancer and should be evaluated together with radiographic imaging

BMC cancer, 2017-03, Vol.17 (1), p.210-210, Article 210

2017

Volltextzugriff (PDF)

First‐Line Cetuximab Plus Capecitabine in Elderly Patients with Advanced Colorectal Cancer: Clinical Outcome and Subgroup Analysis According to KRAS Status from a Spanish TTD Group Study

The oncologist (Dayton, Ohio), 2012-03, Vol.17 (3), p.339-345

2012

Volltextzugriff (PDF)

Nasoethmoidal Intestinal‐Type Adenocarcinoma Treated with Cetuximab: Role of Liquid Biopsy and BEAMing in Predicting Response to Anti‐Epidermal Growth Factor Receptor Therapy

The oncologist (Dayton, Ohio), 2019-03, Vol.24 (3), p.293-300

2019

Volltextzugriff (PDF)

Should capecitabine replace 5-fluorouracil in the first-line treatment of metastatic colorectal cancer?

World journal of gastroenterology : WJG, 2014-05, Vol.20 (20), p.6092-6101

2014

Volltextzugriff (PDF)

1 – 25 von 2.030

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.649)
Mit Volltextzugriff
(1.754)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(33)
... seit 30 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study

Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer

Prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis in metastatic colorectal cancer

Robust discrete‐time output feedback stabilization of integrator chains

Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database

Implicit and explicit discrete‐time realizations of homogeneous differentiators

Persistent diarrhea in immunocompromised patients: Have you ever thought about an astrovirus infection?

Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study

First‐Line XELOX Plus Bevacizumab Followed by XELOX Plus Bevacizumab or Single‐Agent Bevacizumab as Maintenance Therapy in Patients with Metastatic Colorectal Cancer: The Phase III MACRO TTD Study

Patterns of spatial and temporal variability in streamflow records in south central Chile in the period 1952-2003

Individual patient data analysis of progression-free survival versus overall survival as a first-line end point for metastatic colorectal cancer in modern randomized trials: findings from the analysis and research in cancers of the digestive system database

SOD3 improves the tumor response to chemotherapy by stabilizing endothelial HIF-2α

Optimal maintenance strategy following FOLFOX plus anti-EGFR induction therapy in patients with RAS wild type metastatic colorectal cancer: An individual patient data pooled analysis of randomised clinical trials

Intramolecular CH Activation through Gold(I)-Catalyzed Reaction of Iodoalkynes

Phase II Trial of Cetuximab in Combination With Fluorouracil, Leucovorin, and Oxaliplatin in the First-Line Treatment of Metastatic Colorectal Cancer

Behavioural and structural interventions in cancer prevention: towards the 2030 SDG horizon

Phase III Study of Capecitabine Plus Oxaliplatin Compared With Continuous-Infusion Fluorouracil Plus Oxaliplatin As First-Line Therapy in Metastatic Colorectal Cancer: Final Report of the Spanish Cooperative Group for the Treatment of Digestive Tumors Trial

Circulating Tumor Cell Count Is a Prognostic Factor in Metastatic Colorectal Cancer Patients Receiving First‐Line Chemotherapy Plus Bevacizumab: A Spanish Cooperative Group for the Treatment of Digestive Tumors Study

Time–Frequency Approach for Cutting Tool Power Signal Separation in Face Milling Operations

Colon cancer molecular subtypes identified by expression profiling and associated to stroma, mucinous type and different clinical behavior

XELOX (Capecitabine Plus Oxaliplatin): Active First-Line Therapy for Patients With Metastatic Colorectal Cancer

Tumor burden monitoring using cell-free tumor DNA could be limited by tumor heterogeneity in advanced breast cancer and should be evaluated together with radiographic imaging

First‐Line Cetuximab Plus Capecitabine in Elderly Patients with Advanced Colorectal Cancer: Clinical Outcome and Subgroup Analysis According to KRAS Status from a Spanish TTD Group Study

Nasoethmoidal Intestinal‐Type Adenocarcinoma Treated with Cetuximab: Role of Liquid Biopsy and BEAMing in Predicting Response to Anti‐Epidermal Growth Factor Receptor Therapy

Should capecitabine replace 5-fluorouracil in the first-line treatment of metastatic colorectal cancer?

Suchergebnisse filtern